Biome Australia Limited
BIO.AX
Get informed when a big investor buys or sells
+ FollowMarket Cap$92.34M
Close$
$1.11
168% upside
Current Fair Value
168% upsideUndervalued by 168% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $92.34 Million |
|---|---|
| Enterprise Value | $91.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.02 |
| Beta | 0.99 |
| Outstanding Shares | 225,146,000 |
Return
| Return on Equity | 40.76% |
|---|---|
| Return on Assets | 24.32% |
| Return on Invested Capital | 17.52% |
Valuation & Multiples
| P/E Ratio | 25.16 |
|---|---|
| PEG | -2.08 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.17 |
| Enterprise Value to EBIT | 51.04 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$11.50 M
Average shareholder expectationNext Earnings Call
Expected Date
February 23, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$11.78 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biome Australia Limited
30 employees
CEO: Blair William Brabin Vega Norfolk Biome Australia Limited, founded in 2018 and headquartered in Cremorne, Australia, specializes in the development, commercialization, and global distribution of live biotherapeutic and complementary health products. The company's product...